Scilex Holding (SCLX) FCF Margin (2022 - 2026)

Scilex Holding (SCLX) recorded quarterly FCF Margin of 10.47% in Q1 2026, up 102.9% quarter-over-quarter from 360.97% in Q4 2025, and down 10967.0% on a YoY basis from N/an in Q1 2025.

Scilex Holding (SCLX) FCF Margin (2022 - 2026) Analysis & Trends

Scilex Holding's FCF Margin history runs 5 years deep, the most recent figure standing at 10.47% for Q1 2026.

  • In Q1 2026, FCF Margin fell 10967.0% year-over-year to 10.47%; the TTM figure through Mar 2026 stood at 3.81% (down 3529.0% YoY), while the FY2025 annual figure was 12.16%, down 2204.0% from the prior year.
  • FCF Margin was 10.47% for Q1 2026 at Scilex Holding, up from 360.97% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 120.14% in Q1 2025 to a low of 360.97% in Q4 2025.
  • Historically, FCF Margin has averaged 22.8% across 5 years, with a median of 14.12% in 2024.
  • The sharpest annual moves came in 2024 and 2025: FCF Margin surged 15946 bps in 2024, then plunged 37798 bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 6.08% in 2022, then tumbled by 558 bps to 40.05% in 2023, then surged by 142 bps to 17.01% in 2024, then tumbled by 2223 bps to 360.97% in 2025, then surged by 103 bps to 10.47% in 2026.
  • The last three FCF Margin figures came in at 10.47% (Q1 2026), 360.97% (Q4 2025), and 77.53% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 20.59%
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 15.19%
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 6.09%
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 23.76%
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 17.97%
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 17.14%
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 34.87%
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 93.16%
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 6.59%
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn 10.47%

Historic Data

Download Data
DateValue
Mar 31, 2026 10.47%
Dec 31, 2025 -360.97%
Sep 30, 2025 77.53%
Jun 30, 2025 71.68%
Mar 31, 2025 120.14%
Dec 31, 2024 17.01%
Sep 30, 2024 35.42%
Jun 30, 2024 14.12%
Mar 31, 2024 86.28%
Dec 31, 2023 -40.05%
Sep 30, 2023 58.11%
Jun 30, 2023 -107.08%
Mar 31, 2023 -73.18%
Dec 31, 2022 -6.08%
Sep 30, 2022 22.20%
Jun 30, 2022 -155.63%
Mar 31, 2022 -157.53%